Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Treatment of Chlamydia Infection Comparing WC2031 Tablets With Vibramycin

ClinicalTrials.gov ID: NCT01113931

Public ClinicalTrials.gov record NCT01113931. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 6:28 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Safety and Efficacy of WC2031 Versus Vibramycin for the Treatment of Uncomplicated Urogenital Chlamydia Trachomatis Infection: A Randomized, Double-blind, Double-dummy, Active-controlled, Multicenter Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Evaluate the clinical efficacy and safety of WC2031 200 mg tablets taken orally once a day for 7 days versus Vibramycin (doxycycline) 100 mg capsules taken orally twice a day for 7 days, for the treatment of uncomplicated urogenital Chlamydia trachomatis infection. Primary efficacy endpoint is microbiological cure at Day 28. Safety assessments are adverse events, changes in vital signs and laboratory test results.

Study identification

NCT ID
NCT01113931
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Warner Chilcott
Industry
Enrollment
495 participants

Conditions and interventions

Eligibility (public fields only)

Age range
19 Years to 45 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2010 (Type not available)
Primary completion
Oct 2010 (Actual)
Completion
Oct 2010 (Actual)
Last update posted
Jan 27, 2012

2010

United States locations

U.S. sites
43
U.S. states
22
U.S. cities
41
Facility City State ZIP Site status
Research Site Birmingham Alabama 35294 —
Research Site Foley Alabama 36535 —
Research Site Tucson Arizona 85710 —
Research Site Anaheim California 92805 —
Research Site Fresno California 93726 —
Research Site Los Angeles California 90007 —
Research Site San Diego California 92108 —
Research Site Boca Raton Florida 33432 —
Research Site Boynton Beach Florida 33472 —
Research Site Margate Florida 33063 —
Research Site North Miami Florida 33161 —
Research Site South Miami Florida 33143 —
Research Site West Palm Beach Florida 33401 —
Research Site Decatur Georgia 30033 —
Research Site Savannah Georgia 31406 —
Research Site Chicago Illinois 60613 —
Research Site Indianapolis Indiana 46202 —
Research Site Arkansas City Kansas 67005 —
Research Site Newton Kansas 67114 —
Research Site Wichita Kansas 67207 —
Research Site Marrero Louisiana 70072 —
Research Site New Orleans Louisiana 70112 —
Research Site New Orleans Louisiana 70115 —
Research Site Fall River Massachusetts 02720 —
Research Site Detroit Michigan 48201 —
Research Site Jackson Mississippi 39213 —
Research Site Las Vegas Nevada 89106 —
Research Site Las Vegas Nevada 89109 —
Research Site North Las Vegas Nevada 89030 —
Research Site Brooklyn New York 11203 —
Research Site Greensboro North Carolina 27405 —
Research Site New Bern North Carolina 28562 —
Research Site Raleigh North Carolina 27612 —
Research Site Columbus Ohio 43231 —
Research Site Oklahoma City Oklahoma 73120 —
Research Site Jefferson Hills Pennsylvania 15025 —
Research Site Jenkintown Pennsylvania 19046 —
Research Site Myrtle Beach South Carolina 29572 —
Research Site Houston Texas 77030 —
Research Site San Antonio Texas 78229 —
Research Site Norfolk Virginia 23507 —
Research Site Spokane Washington 99207 —
Research Site Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01113931, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 27, 2012 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01113931 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →